Search
for
Sort by
Research 181–210 of 1000+
- Hidradenitis suppurativa: an-androgen-dependent disorder
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Psychotropic Treatment of Psychodermatologic Disorders
- Update on medical management of benign prostatic hyperplasia
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- The role of androgen and androgen receptor in skin-related disorders
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Retorno de la fertilidad en un perro con un abscesso prostático
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Abstract 850: Androgenic alopecia and risks of overall and aggressive prostate cancer: An updated meta-analysis
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Intracavernous injection of platelet‐rich plasma reverses erectile dysfunction of chronic cavernous nerve degeneration through reduction of prostate hyperplasia evidence from an aging‐induced erectile dysfunction rat model
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate